Company intelligence / Profile preview

KabaFusion

Cerritos, California, United Statesbiospace.com ↗
Ownership
Private
Employees
~1700
Development stage
Commercial
01

Overview

KabaFusion operates a nationwide network of accredited home infusion pharmacies and ambulatory suites. It specializes in the delivery of intravenous/subcutaneous immunoglobulin therapies as well as a broad range of acute and chronic infusion treatments. The company has demonstrated strong growth through acquisitions, including recent expansion into new states with the acquisition of Coram’s assets. Clinical outcomes are supported by dedicated nursing staff and pharmacist oversight. No clinical trial data reported; services are commercial standard-of-care.

Therapeutic areas
ImmunologyOtherGastroenterologyNeurologyInfectious Diseases
Modalities
BiologicSmall moleculeProtein
Industry
Non-Academic Healthcare
02

Drug pipeline

1 asset

ALYGLO

Commercial
Indications
Primary Humoral Immunodeficiency
03

Partnerships

Major payors including Medicare, Medicaid, Blue Cross Blue Shield, Aetna, UnitedHealthcare; partnerships with physicians/manufacturers implied but not named specifically.

Beyond the preview

Go deeper on KabaFusion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KabaFusion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call